Prothrombin concentrates as hemostyptics
Egli, H.
Münchener Medizinische Wochenschrift 113(Suppl 4): 1
1971
ISSN/ISBN: 0341-3098 PMID: 5107530 Document Number: 38149
Document emailed within 1 workday
Related Documents
Blatt, P.M.; Pearsall, A.H.; Givhan, E.G.; Hallum, C.E.; Roberts, H.R.; Webster, W.P. 1980: Haemostatic failure of prothrombin complex concentrates during elective dental procedure Thrombosis and Haemostasis 42(5): 1604-1606Takeda, Y. 1970: Studies of the effects of heparin, Coumadin, and vitamin K on prothrombin metabolism and distribution in calves with the use of iodine-125-prothrombin. Characterization of the prothrombin system Journal of Laboratory and Clinical Medicine 75(3): 355-381
Ono, M.; Ohta, H.; Ohhira, M.; Sekiya, C.; Namiki, M. 1990: Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin, and vitamin K in human liver tissues: overproduction of immunoreactive prothrombin in hepatocellular carcinoma American Journal of Gastroenterology 85(9): 1149-1154
Mergard, U.; Köhnlein, H.E. 1972: Effect of various hemostyptics in animal experiment Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 43(9): 411-415
Akhavan, S.; Lavoretano, S.; Chantarangkul, V.; Mannucci, P.M. 2002: Plasma prothrombin levels are not associated with mutations in the promoter region of the prothrombin gene Thrombosis and Haemostasis 88(5): 877-878
Rao, L.V.; Hoang, A.D.; Rapaport, S.I. 1995: Differences in the interactions of lupus anticoagulant IgG with human prothrombin and bovine prothrombin Thrombosis and Haemostasis 73(4): 668-674
Jaekel H.-P.; Trabandt A.; Schmid D.; Grobe N.; Müller E.-W.; Ziutelis V.; Kaskel-Paul S.; Höh H.; Bauer B.; Sudik R.; Baldauf A.; Werle E. 2004: Autoantibodies to Prothrombin and Phosphatidylserine/Prothrombin-Complexes: Do they contribute to the Serodiagnosis of Primary and Secondary Anti-Phospholipid Syndrome? Clinical Laboratory 50(5-6): 295-304
Degen, S.J.; McDowell, S.A.; Sparks, L.M.; Scharrer, I. 1995: Prothrombin Frankfurt: a dysfunctional prothrombin characterized by substitution of Glu-466 by Ala Thrombosis and Haemostasis 73(2): 203-209
Menache, D. 1990: New concentrates of factors VII, IX and X Progress in Clinical and Biological Research 324: 177-187
Fortýnová, J.; Korínková, P.; Vopatová, M. 1988: Platelet concentrates Casopis Lekaru Ceskych 127(10): 292-297
Jovanović, R.; Erceg, S.; Rakić, S. 1996: Use and preparation of thrombocyte concentrates Medicinski Pregled 49(7-8): 301-304
Nyman, D. 1975: Clinical use of factor IX concentrates Schweizerische Medizinische Wochenschrift 105(37): 1188-1190
Brinch, L.; Evensen, S.A.; Stavem, P.; Solheim, B.G. 1988: Use and abuse of platelet concentrates Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 108(22): 1632-1634
Hantschel, H.; Liebermann, H.; Thalmann, G. 1985: Production of picornavirus concentrates using ultrafiltration Archiv für Experimentelle Veterinarmedizin 39(5): 723-729
Dornheim, G.; Töpfer, G. 1987: Comparative study of antithrombin IIi concentrates Die Pharmazie 42(12): 867-868
Mariani, G.; Di Nucci, G.D.; Arcieri, P. 1994: Immunopurified clotting factor concentrates Nouvelle Revue Francaise d'Hematologie 36(Suppl 1): S61-S65
Magner, A.; Aronson, D. 1979: Toxicity of factor IX concentrates in mice Developments in Biological Standardization 44: 185-188
Vicente, V. 1989: Plasma concentrates of factor VIII. Where are we? Sangre 34(1): 1-3
Lusher, J.M. 1991: Thrombogenicity associated with factor IX complex concentrates Seminars in Hematology 28(3 Suppl 6: 3-5
CF Weber; MU Heim 2011: Pathogen-Reduction for Platelet Concentrates Clinical Laboratory 57(5-6): 293-295